B-mode ultrasound examinations have been useful in demonstrating cholelithiasis and obstructive dilatation of the gallbladder. It is now possible with gray scale ultrasound technique to demonstrate dilatation of the common bile duct, as differentiated from the gallbladder, and also to show fluid containing spaces within the liver. Discrimination between solid and fluid filled intrahepatic structures is readily made, and dilated biliary radicles are frequently discernible.

Download full-text PDF

Source
http://dx.doi.org/10.2214/ajr.125.1.47DOI Listing

Publication Analysis

Top Keywords

gray scale
8
scale ultrasound
8
ultrasound diagnosis
4
diagnosis obstructive
4
obstructive biliary
4
biliary disease
4
disease b-mode
4
b-mode ultrasound
4
ultrasound examinations
4
examinations demonstrating
4

Similar Publications

Development of a framework to structure decision-making in environmental and occupational health: A systematic review and Delphi study.

Environ Int

December 2024

Cochrane Canada and McMaster GRADE Centres & Department of Health Research Methods, Evidence and Impact, McMaster University, Health Sciences Centre, Room 2C14, 1280 Main Street West, Hamilton, ON L8S 4K1, Canada; School of Medicine, Case Western Reserve University, 10900 Euclid Ave, Cleveland, OH 44106, USA. Electronic address:

Background: Environmental and occupational health (EOH) assessments increasingly utilize systematic review methods and structured frameworks for evaluating evidence about the human health effects of exposures. However, there is no prevailing approach for how to integrate this evidence into decisions or recommendations. Grading of Recommendations Assessment, Development and Evaluation (GRADE) evidence-to-decision (EtD) frameworks provide a structure to support standardized and transparent consideration of relevant criteria to inform health decisions.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

GE HealthCare, Amersham, UK.

Background: The Centiloid method (CL) was introduced as a tracer-independent measure for cortical amyloid load and is now commonly used in Alzheimer's disease (AD) clinical trials. To facilitate its implementation into clinical settings, the AMYPAD consortium set out to integrate existing literature and recent work from the consortium to provide clinical context-of-use recommendations of the Centiloid scale, which has been submitted to the European Medicine Agency for endorsement as a Biomarker Qualification Opinion.

Method: Screening of the literature was performed on the 7/11/23 on PubMed to identify articles mentioning "Centiloid".

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada.

Background: Social cognition is impacted early in the disease progression of many neurodegenerative diseases (ND). The Salience network (SN) is an intrinsically connected brain network responsible for social cognitive function. Keys hubs of this brain network, the anterior insula (AI) and anterior cingulate cortex (ACC), are reported to incorporate 'bottom-up' signals from subcortical regions such as the amygdala and periaqueductal gray (PAG), but this mechanism and the subcortical contribution to SN connectivity is poorly understood.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

National Institute on Aging, National Institutes of Health, Baltimore, MD, USA.

Background: AD is defined by cortical amyloid-β (Aβ), tau neurofibrillary tangles, and neurodegeneration, pathological processes which may contribute to cognitive decline by altering large scale functional brain networks. To test this hypothesis, we examined whether plasma biomarkers of AD pathology (Aβ, phosphorylated tau [pTau-181]), astrogliosis (glial fibrillary acidic protein [GFAP]), and neuronal injury (neurofilament light chain [NfL]) related to longitudinal changes in resting-state functional connectivity (rsFC) in cognitively unimpaired participants from the Baltimore Longitudinal Study of Aging.

Method: Baseline plasma biomarkers were measured with Quanterix SIMOA assays.

View Article and Find Full Text PDF

Background: Tau-PET tracers have been used to diagnose and stage Alzheimer's disease. However, different tau tracers present distinct patterns of binding throughout the brain, challenging the harmonization of their results. We hypothesize that the choice of a reference region can impact the harmonization of the tau-PET standardized uptake value ratio (SUVR).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!